[go: up one dir, main page]

SE8803935L - Laekemedelskomposition - Google Patents

Laekemedelskomposition

Info

Publication number
SE8803935L
SE8803935L SE8803935A SE8803935A SE8803935L SE 8803935 L SE8803935 L SE 8803935L SE 8803935 A SE8803935 A SE 8803935A SE 8803935 A SE8803935 A SE 8803935A SE 8803935 L SE8803935 L SE 8803935L
Authority
SE
Sweden
Prior art keywords
pharmaceutical substance
composition
laekemedelskomposition
pharmaceutical
finely
Prior art date
Application number
SE8803935A
Other languages
Unknown language ( )
English (en)
Other versions
SE8803935D0 (sv
Inventor
C Nystroem
Original Assignee
Kabivitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20373813&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8803935(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kabivitrum Ab filed Critical Kabivitrum Ab
Priority to SE8803935A priority Critical patent/SE8803935L/sv
Publication of SE8803935D0 publication Critical patent/SE8803935D0/sv
Priority to AU44808/89A priority patent/AU4480889A/en
Priority to EP89911914A priority patent/EP0440702B1/en
Priority to AT89911914T priority patent/ATE104141T1/de
Priority to PCT/SE1989/000599 priority patent/WO1990004962A1/en
Priority to DE68914683T priority patent/DE68914683T2/de
Publication of SE8803935L publication Critical patent/SE8803935L/sv
Priority to SE9101027A priority patent/SE466088B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8803935A 1988-10-31 1988-10-31 Laekemedelskomposition SE8803935L (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE8803935A SE8803935L (sv) 1988-10-31 1988-10-31 Laekemedelskomposition
AU44808/89A AU4480889A (en) 1988-10-31 1989-10-27 A pharmaceutical composition for rapid release of the active component comprising an orderred mixture and a surfactant
EP89911914A EP0440702B1 (en) 1988-10-31 1989-10-27 A pharmaceutical composition for rapid release of the active component comprising a solid dispersion and a surfactant
AT89911914T ATE104141T1 (de) 1988-10-31 1989-10-27 Arzneimittelzusammensetzung fuer die schnelle verabreichung des aktiven bestandteils, der aus einer festen dispersion und einem oberflaechenaktiven mittel besteht.
PCT/SE1989/000599 WO1990004962A1 (en) 1988-10-31 1989-10-27 A pharmaceutical composition for rapid release of the active component comprising an orderred mixture and a surfactant
DE68914683T DE68914683T2 (de) 1988-10-31 1989-10-27 Arzneimittelzusammensetzung für die schnelle verabreichung des aktiven bestandteils, der aus einer festen dispersion und einem oberflächenaktiven mittel besteht.
SE9101027A SE466088B (sv) 1988-10-31 1991-04-08 Laekemedelskomposition foer snabbt frigoerande av aktiv laekemedelssubstans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8803935A SE8803935L (sv) 1988-10-31 1988-10-31 Laekemedelskomposition

Publications (2)

Publication Number Publication Date
SE8803935D0 SE8803935D0 (sv) 1988-10-31
SE8803935L true SE8803935L (sv) 1990-05-01

Family

ID=20373813

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8803935A SE8803935L (sv) 1988-10-31 1988-10-31 Laekemedelskomposition

Country Status (5)

Country Link
EP (1) EP0440702B1 (sv)
AU (1) AU4480889A (sv)
DE (1) DE68914683T2 (sv)
SE (1) SE8803935L (sv)
WO (1) WO1990004962A1 (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
TW402506B (en) 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
CZ295827B6 (cs) 1994-03-07 2005-11-16 Nektar Therapeutics Způsob aerosolizace dávky inzulinu, inzulinový přípravek a jeho použití
EE9700138A (et) 1994-12-22 1997-12-15 Astra Aktiebolag Aerosoolravimvormid
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
US6531158B1 (en) * 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
JP2005523262A (ja) 2002-02-01 2005-08-04 ファイザー・プロダクツ・インク 薬物及び親油性ミクロ相形成物質の非晶質分散物の医薬組成物
WO2005011635A2 (en) 2003-08-04 2005-02-10 Pfizer Products Inc. Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
GB0423800D0 (en) 2004-10-27 2004-12-01 Orexo Ab New pharmaceutical formulations
WO2006085101A2 (en) * 2005-02-10 2006-08-17 Orexo Ab Pharmaceutical compositions useful in the transmucosal administration of drugs
WO2006103407A2 (en) * 2005-03-28 2006-10-05 Orexo Ab New pharmaceutical compositions useful in the treatment of migraine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE5852T1 (de) * 1978-11-20 1984-02-15 American Home Products Corporation Therapeutische zusammensetzungen mit gesteigerter bioverfuegbarkeit und verfahren zu deren herstellung.
US4629621A (en) * 1984-07-23 1986-12-16 Zetachron, Inc. Erodible matrix for sustained release bioactive composition
WO1987000428A1 (en) * 1985-07-24 1987-01-29 Pyare Seth Oxazepam containing pharmaceutical composition

Also Published As

Publication number Publication date
EP0440702A1 (en) 1991-08-14
WO1990004962A1 (en) 1990-05-17
AU4480889A (en) 1990-05-28
SE8803935D0 (sv) 1988-10-31
EP0440702B1 (en) 1994-04-13
DE68914683T2 (de) 1994-10-27
DE68914683D1 (de) 1994-05-19

Similar Documents

Publication Publication Date Title
ATE69141T1 (de) Nikotin enthaltende tablette.
DK393187A (da) Laegemiddel med antitumorvirkning
DK588487A (da) Forbedrede metalholdige farmaceutiske midler
DE68903846D1 (de) Neue galenische form von fenofibrat.
BR8801396A (pt) Composto,mistura polimerizavel por radiacao e material de registro
BR8805981A (pt) Composto,mistura polimerizavel por radiacao e material de registro polimerizavel por radiacao
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
SE8803935D0 (sv) Laekemedelskomposition
ES2019398B3 (es) Nueva composicion para alimentacion de rumiantes, que contiene una sustancia biologicamente activa y su preparacion.
IT8721411A0 (it) Composizione farmaceutica idrosolubile contenente n acetilsisteina.
IT8721410A0 (it) Composizione farmaceutica idrosolubile contenente n acetilcisteina.
ES2157886T3 (es) Composiciones tensioactivas y procedimientos.
ATE138590T1 (de) Pyrogensorbentmittel
NO870397D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive organiske platinakomplekser.
NO902626L (no) Fremgangsmaate for stabilisering av biologisk aktive forbindelser immobilisert paa faste faser.
SE8800080D0 (sv) Lekemedelskomposition
TR24383A (tr) Konsantre yuezey aktif madde granuelleri yapmaya mahsus yoentem
DK524489A (da) Fremgangsmaade til fremstilling af biologisk aktive forbindelser, specielt enzymer
IL87778A0 (en) Pharmaceutical compositions containing stabilized therapeutically active proteins and their preparation
SE8306225L (sv) 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
IT1241396B (it) Composizioni tensioattive, loro preparazione e loro impiego come agenti antischiuma. (caso 150-5294)
EP0316639A3 (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
SE8503447L (sv) Farmaceutiska och kosmetiska kompositioner, innehallande dihydroxi-1,8-fenyl-10-antron-9 som verksam bestandsdel, samt sett att framstella den verksamma foreningen
ES2051953T3 (es) Derivados isomeros de trimetilbiciclo(4,3,0)nonano.
GR3005235T3 (sv)